Related Experiment Video
Updated: Dec 23, 2025
09:14
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
11.3K
Vaccination against Respiratory Syncytial Virus.
Christopher A Green1,2, Simon B Drysdale3,4, Andrew J Pollard3
1Oxford Vaccine Group, Department of Paediatrics and the NIHR Oxford, Biomedical Research Centre, University of Oxford, Oxford, United Kingdom, christopher.green@paediatrics.ox.ac.uk.
Interdisciplinary Topics in Gerontology and Geriatrics
|April 20, 2020
Summary
Respiratory syncytial virus (RSV) poses significant health risks, especially for the elderly. Developing an effective RSV vaccine remains a priority due to past failures and challenges in understanding immune responses.
Area of Science:
- Immunology
- Vaccinology
- Virology
Background:
- Respiratory syncytial virus (RSV) infection occurs throughout life, posing severe risks for infants, immunocompromised adults, and the elderly, comparable to influenza.
- Despite significant disease burden and mortality, no effective antiviral drugs or vaccines currently exist for RSV in any population.
- Developing an RSV vaccine is a global health priority, yet numerous candidates have failed in large-scale clinical trials.
Purpose of the Study:
- To review the challenges and recent advances in developing an effective RSV vaccine, particularly for the elderly.
- To highlight the need for a better understanding of immune responses required for protection against RSV.
- To discuss the impact of aging on immunity and the presence of co-morbidities in older adults concerning vaccine efficacy.
Main Methods:
- Review of recent scientific literature and clinical trial data on RSV vaccine development.
- Analysis of advances in structural biology and new antigen delivery platforms.
- Examination of insights gained from experimental challenge models in RSV research.
Main Results:
- Multiple safe and immunogenic RSV vaccine candidates have failed to achieve protective immunity for licensure.
- Obstacles include incomplete understanding of protective immune responses, aging's effect on immunity, and co-morbidities in the elderly.
- Recent progress in structural biology and delivery platforms offers renewed hope.
Conclusions:
- RSV vaccine development for the elderly faces significant hurdles related to immune response and aging.
- Continued research integrating structural biology, novel platforms, and challenge models is crucial.
- Despite past setbacks, ongoing scientific discovery provides optimism for future RSV vaccine availability.
More Related Videos
Related Concept Videos
01:51Vaccinations
50.9K
Overview
50.9K
01:31Common Respiratory Disorders
1.2K
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.2K
01:03Rous Sarcoma Virus (RSV) and Cancer
6.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.0K
01:30Pneumonia V: Nursing management and Prevention
3.3K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.3K
01:29Acute Respiratory Failure-V
372
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
372
01:21Acute Respiratory Failure-II
911
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
911